OBJECTIVE: To analyze the clinical effects of neuroendoscopic hematoma evacuation for the treatment of hypertensive intracerebral hemorrhage (ICH). METHODS: A total of 80 patients with hypertensive ICH who were admitted to our hospital were included as the subjects of this retrospective study. The patients were assigned into a neuroendoscopic hematoma evacuation group (n=35) and a small bone window craniotomy group (n=45). The post-operative hematoma residues and the clearance rate of the hematoma were compared between the two groups. The intraoperative blood loss, duration of the surgery, and Glasgow Coma Scale (GSC) scores before and after surgery were compared between the two groups. The operation time, intraoperative blood loss, the time consumed to stop bleeding, clearance rate of hematoma, manifestation of complications, and the prognosis 6 months after surgery were analyzed statistically. Self-made questionnaires were used to evaluate the satisfaction degree of patients with their lives and to assess the quality of life after surgery. RESULTS: The operation time, blood loss, and the time consumed to stop bleeding were less in the neuroendoscopic hematoma evacuation group than those in the small bone window craniotomy group (all P<0.05). The GCS scores in the neuroendoscopic hematoma evacuation group were significantly higher than those in the small bone window craniotomy group (P<0.05). The clearance rate of hematoma was higher in the neuroendoscopic hematoma evacuation group than that in the small bone window craniotomy group (P<0.05). CONCLUSION: As compared with small bone window craniotomy for removing hematoma, neuroendoscopic hematoma evacuation showed a better outcome in treating patients with hypertensive ICH. It could improve patients' clinical indications, which is worthy of being widely applied in clinical settings. AJTR
OBJECTIVE: To analyze the clinical effects of neuroendoscopic hematoma evacuation for the treatment of hypertensive intracerebral hemorrhage (ICH). METHODS: A total of 80 patients with hypertensive ICH who were admitted to our hospital were included as the subjects of this retrospective study. The patients were assigned into a neuroendoscopic hematoma evacuation group (n=35) and a small bone window craniotomy group (n=45). The post-operative hematoma residues and the clearance rate of the hematoma were compared between the two groups. The intraoperative blood loss, duration of the surgery, and Glasgow Coma Scale (GSC) scores before and after surgery were compared between the two groups. The operation time, intraoperative blood loss, the time consumed to stop bleeding, clearance rate of hematoma, manifestation of complications, and the prognosis 6 months after surgery were analyzed statistically. Self-made questionnaires were used to evaluate the satisfaction degree of patients with their lives and to assess the quality of life after surgery. RESULTS: The operation time, blood loss, and the time consumed to stop bleeding were less in the neuroendoscopic hematoma evacuation group than those in the small bone window craniotomy group (all P<0.05). The GCS scores in the neuroendoscopic hematoma evacuation group were significantly higher than those in the small bone window craniotomy group (P<0.05). The clearance rate of hematoma was higher in the neuroendoscopic hematoma evacuation group than that in the small bone window craniotomy group (P<0.05). CONCLUSION: As compared with small bone window craniotomy for removing hematoma, neuroendoscopic hematoma evacuation showed a better outcome in treating patients with hypertensive ICH. It could improve patients' clinical indications, which is worthy of being widely applied in clinical settings. AJTR
Authors: William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell Journal: Stroke Date: 2018-01-24 Impact factor: 7.914
Authors: Alberto Sibilla; Peter Nydahl; Nicola Greco; Giuseppe Mungo; Natalie Ott; Ines Unger; Spencer Rezek; Sarah Gemperle; Dale M Needham; Sapna R Kudchadkar Journal: J Intensive Care Med Date: 2017-08-29 Impact factor: 3.510
Authors: Mette M B Nielsen; Kate L Lambertsen; Bettina H Clausen; Morten Meyer; Dhaka R Bhandari; Søren T Larsen; Steen S Poulsen; Bernhard Spengler; Christian Janfelt; Harald S Hansen Journal: Sci Rep Date: 2016-12-22 Impact factor: 4.379
Authors: Pamela W Duncan; Cheryl D Bushnell; Wayne D Rosamond; Sara B Jones Berkeley; Sabina B Gesell; Ralph B D'Agostino; Walter T Ambrosius; Blair Barton-Percival; Janet Prvu Bettger; Sylvia W Coleman; Doyle M Cummings; Janet K Freburger; Jacqueline Halladay; Anna M Johnson; Anna M Kucharska-Newton; Gladys Lundy-Lamm; Barbara J Lutz; Laurie H Mettam; Amy M Pastva; Mysha E Sissine; Betsy Vetter Journal: BMC Neurol Date: 2017-07-17 Impact factor: 2.474
Authors: Audrey M Johnson; Angela N Henning; Peter E Morris; Alejandro G Villasante Tezanos; Esther E Dupont-Versteegden Journal: Sci Rep Date: 2017-12-14 Impact factor: 4.379